|
2971
|
Amcasertib
|
First-in-class stemness kinase inhibitor |
€145.00 |
|
2837
|
BMS 605541
|
Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor |
€90.00 |
|
2895
|
D3-βArr
|
Positive allosteric modulator (PAM) of TSH receptor |
€105.00 |
|
2947
|
JTP 1048196
|
Prodrug of JTP 0819958; LUBAC inhibitor |
€125.00 |
|
2955
|
NSC 228155
|
EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction |
€75.00 |
|
2817
|
RAF709
|
Potent, selective, and efficacious B-Raf and C-Raf protein kinase inhibitor |
€120.00 |
|
2950
|
Rigosertib sodium
|
Non-ATP-competitive PLK1 inhibitor |
€95.00 |
|
2953
|
Roblitinib
|
First-in-class, highly selective and potent FGFR4 inhibitor |
€125.00 |
|
2956
|
Selonsertib
|
Potent, highly selective, orally available, and ATP-competitive ASK1 inhibitor |
€90.00 |
|
2934
|
TH 5487
|
Potent and selective active-site OGG1 inhibitor |
€125.00 |
|
2951
|
XL 388
|
Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor |
€125.00 |